LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EQUITY FLASH L impact Sep 25, 2026, 12:46 PM UTC

Freight Futures AM Update Dry Bulk Capesize: down ~3% Panamax: down ~2% Tankers VLCC: flat Suezmax: up ~1%

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Big-cap premarket movers rise on deals, ratings AKAM rose 13% after announcing an $11.6 billion multi-year agreement with Anthropic. GENI, FRVO, CIFR and PGEN also gained on analyst action or a lease-term expansion. L impact | EQUITY | Sep 25, 2026, 01:07 PM UTC Small-cap premarket movers include INLF, MGLD and AIFF INLF rose after first-half fiscal 2026 results. MGLD gained after Madison Dearborn Partners agreed to acquire The Marygold Companies. AIFF rose after a partnership with NeuroSigma M impact | EQUITY | Sep 25, 2026, 01:07 PM UTC Guggenheim maintains Buy rating on Damora Therapeutics, $60 price target Guggenheim maintained their Buy rating on Damora Therapeutics's stock with a price target of $60.00.The price target implies an upside of 196.0% from the Sep 24 close of $20.27.Key L impact | EQUITY | Sep 25, 2026, 01:04 PM UTC Cadiz Inc. Declares Quarterly Dividend for Q3 2026 on Series A Cumulative Perpetual Preferred Stock LOS ANGELES, Sept. 25, 2026 // -- Cadiz, Inc. (NASDAQ:CDZI / CDZIP) ("Cadiz," the "Company"), a California water solutions company, today announced that its Board of Directors has L impact | EQUITY | Sep 25, 2026, 01:03 PM UTC Guggenheim initiates coverage of Entera Bio with Buy rating, $11 price target Guggenheim initiated coverage on Entera Bio's stock with a rating of Buy and a price target of $11.00.The price target implies an upside of 292.9% from the Sep 24 close of $2.80.Ke L impact | EQUITY | Sep 25, 2026, 01:03 PM UTC Nscale Raises $3.36B In Pre-IPO Convertible Financing NVIDIA Corporation NASDAQ:NVDA L impact | EQUITY | Sep 25, 2026, 01:02 PM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.